FindTrial
Sign In

SGLT2 inhibitor (Dapagliflozin 10mg)

DRUG2 trials

Sponsors

The University of Hong Kong, Ain Shams University

Conditions

Cardiac FibrosisCardiac RemodelingCongenital Heart DiseaseDapagliflozin (Forxiga)Heart Failure - NYHA II - IVPulmonary RegurgitationRepaired Tetralogy of Fallot (rTOF)Sodium-glucose Cotransporter 2 (SGLT2) Inhibitor

Phase 4

Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary Status Trial
RecruitingNCT06668389
The University of Hong KongCongenital Heart Disease, Dapagliflozin (Forxiga), Pulmonary Regurgitation +2
Start: 2025-05-12End: 2026-12-31Target: 106Updated: 2025-05-20

Unknown Phase

Effect of Genetic Polymorphism on the Clinical Outcome to SGLT2 Inhibitors in Heart Failure Patients
Active, not recruitingNCT06901609
Ain Shams UniversityCardiac Fibrosis, Cardiac Remodeling, Heart Failure - NYHA II - IV
Start: 2023-11-22End: 2025-07-01Target: 200Updated: 2025-03-30